Media-OutReach Newswire Berlin Cures' BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Media-OutReach Newswire Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Media-OutReach Newswire Consumers in Singapore are inadequately protected against increasing cancer cases and relapses
Media-OutReach Newswire The largest scientific conference of heart rhythm in Asia Pacific begins Global experts explore cardiac knowledge and advancements in HK
Society University Medical Centre successfully implements minimally invasive pulmonary valve replacement
Media-OutReach Newswire LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China